Hydrocephalus in Children

CSF Dynamics and Pressure Regulation

• The choroid plexus produces approximately 20 mL/hour of CSF (~500 mL/day in children), which normally circulates from the lateral ventricles through the interventricular foramina (foramina of Monro) to the third ventricle, then through the aqueduct of Sylvius to the fourth ventricle, and exits via the foramina of Magendie (midline) and Luschka (lateral) into the subarachnoid space for reabsorption by arachnoid granulations
• Normal intracranial pressure in children is 10-15 mmHg; increased ICP occurs when CSF production exceeds absorption or when flow is obstructed

Obstructive (Non-Communicating) Hydrocephalus

• Mechanical blockage occurs at any point along the ventricular pathway, most commonly at the aqueduct of Sylvius (accounts for 40-50% of congenital cases)
• Results in selective dilation of ventricles proximal to the obstruction while distal ventricles remain normal or small
• Pressure gradient develops across the blockage site, causing transependymal CSF filtration into brain parenchyma and periventricular white matter edema

Communicating Hydrocephalus

• Impaired absorption of CSF occurs despite patent ventricular system and open communication with subarachnoid space
• Typically results from arachnoid granulation dysfunction, subarachnoid scarring, or impaired lymphatic drainage
• All ventricles dilate uniformly; CSF can reach subarachnoid space but is not adequately reabsorbed

Secondary Mechanisms

• Choroid plexus overproduction (rare cause in papillomas or vascular malformations)
• Ventricular compliance reduction in infants (open sutures normally accommodate some ventricular enlargement)
• Increased CSF viscosity or protein content reducing flow dynamics

Congenital Causes (60-70% of pediatric hydrocephalus)

• Neural tube defects: Myelomeningocele with Chiari type II malformation (most common cause of congenital hydrocephalus; 80-90% require shunting)
• Chiari malformations: Type I-IV, with type II most commonly causing hydrocephalus in children
• Aqueductal stenosis: Intrinsic narrowing of the aqueduct of Sylvius; may be idiopathic or associated with genetic mutations (L1CAM gene mutations in X-linked hydrocephalus)
• Dandy-Walker malformation: Hypoplasia of cerebellar vermis, enlargement of fourth ventricle, elevated tentorium; associated with other CNS abnormalities (50% of cases)
• Arnold-Chiari malformation: Cerebellar tonsillar herniation through foramen magnum
• Intrauterine infections: TORCH infections (toxoplasmosis, cytomegalovirus, rubella), particularly CMV causing periventricular calcifications and ependymitis
• Genetic syndromes: Walker-Warburg syndrome, Meckel-Gruber syndrome, Klippel-Feil syndrome

Acquired Causes (30-40% of pediatric hydrocephalus)

• Post-hemorrhagic: Intraventricular hemorrhage in premature infants (most common acquired cause), subarachnoid hemorrhage, epidural/subdural hemorrhage
• Infection: Bacterial meningitis (Streptococcus pneumoniae, Neisseria meningitidis, Group B Streptococcus in neonates), tuberculous meningitis causing thick exudative arachnoiditis with CSF loculation, fungal meningitis
• Intracranial mass: Brain tumors (medulloblastoma, ependymoma, brainstem glioma causing fourth ventricle obstruction), pineal region tumors
• Spinal pathology: Spinal cord tumors, tethered spinal cord causing obstructive hydrocephalus
• Thrombosis: Cerebral venous sinus thrombosis reducing CSF absorption
• Arachnoiditis: Post-traumatic, post-infectious, hemorrhagic

Risk Factors for Congenital Hydrocephalus

• Maternal folate deficiency
• Diabetic maternal hyperglycemia
• Intrauterine infections during first and second trimester
• Family history of neural tube defects or hydrocephalus
• Advanced maternal age

Acute Presentation (Infants with Open Sutures)

• Bulging anterior fontanelle (even when infant is upright and not crying) - most sensitive sign in infants
• Rapidly increasing head circumference crossing percentile curves (may increase 2-3 cm/week in severe cases); frontotemporal bossing
• Prominent scalp veins with increased vascular visibility
• "Sunset sign" - downward deviation of eyes with visible sclera above iris due to upward gaze palsy from tectal compression
• High-pitched "hydrocephalic cry" or weak cry
• Poor feeding, vomiting (often projectile), irritability
• Developmental regression or failure to achieve developmental milestones
• Seizures (occur in 10-15% of children with hydrocephalus)
• Lethargy, altered mental status, decreased level of consciousness
• Posturing or abnormal reflexes in advanced cases

Chronic Presentation (Older Children or Gradual Onset)

• Headaches - often worse in morning, relieved by vomiting; may worsen with position change or Valsalva maneuver
• Progressive cognitive decline and learning difficulties
• Gait disturbance - "magnetic gait" or shuffling gate from increased intracranial compliance
• Visual changes from papilledema (optic disc swelling, blurred vision) or sixth nerve palsy (nonlocalizing sign of raised ICP causing medial rectus weakness)
• Nystagmus or downward gaze preference
• Ataxia and incoordination
• Behavioral changes and personality disturbances
• Growth hormone deficiency causing growth retardation

Physical Examination Findings

• Fontanelle assessment: Palpate anterior fontanelle with infant upright and calm; fullness, tenseness, or bulging indicates elevated ICP
• Papilledema: Optic disc swelling, blurred disc margins, obscured cup, loss of spontaneous venous pulsations; absent in young infants due to open sutures accommodating pressure
• Cranial nerve examination abnormalities:
• Abducens nerve (CN VI) palsy with medial rectus weakness and inability to abduct eye
• Vertical gaze palsy from dorsal midbrain compression (Parinaud syndrome)
• Motor examination: Hyperreflexia, spasticity, upper extremity predominance in tone abnormalities
• Gait assessment: Ataxia, inability to tandem walk (if age-appropriate)
• Presence of lower extremity neurologic deficits: Indicates spinal involvement (myelomeningocele, tethering)

Clinical Suspicion Triggers

• Rapidly enlarging head circumference in infant
• Bulging fontanelle beyond age 18 months
• Persistent vomiting with headaches in child with prior CNS pathology
• Developmental delay or regression
• Gait disturbance with visual complaints

Neuroimaging (Gold Standard)

• Cranial ultrasound: First-line imaging in infants with open fontanelle; excellent for bedside assessment and serial monitoring; demonstrates:
• Lateral ventricle size (normal anterior horn diameter <10 mm in term infants)
• Ventricular index (ratio of maximal lateral ventricle width to hemispheric width; >50% suggests ventriculomegaly)
• Echo density suggesting intraventricular hemorrhage
• Cavum septum pellucidum and cavum vergae patency

• Magnetic resonance imaging (MRI): Gold standard once sutures close; superior for anatomic detail and identification of obstructive lesions:
• T2-weighted sequences: Demonstrates ventricle size, CSF signal intensity, periventricular edema (hyperintense signal surrounding lateral ventricles indicating transependymal CSF flow)
• Identifies specific pathology: aqueductal stenosis, Chiari malformation, mass lesions, neural tube defects
• Cine MRI: Quantifies CSF flow rates through aqueduct; reduced flow (<5 mL/sec) or altered flow patterns suggest obstruction

• Computed tomography: Second-line imaging when MRI contraindicated; inferior soft tissue resolution but identifies:
• Acute hemorrhage (hyperdense intraventricular blood)
• Calcifications (CMV, toxoplasmosis)
• Bony abnormalities
• Acute mass effect and herniation signs

Laboratory Studies

• CSF analysis (obtained via lumbar puncture or ventricular tap only when safe and clinically indicated):
• Opening pressure: Normal 10-15 cm H₂O; elevated in hydrocephalus (>20 cm H₂O)
• Cell count, glucose, protein, cultures, viral PCR
• Helps identify infectious causes (meningitis, ventriculitis)
• Note: LP contraindicated in acute hydrocephalus with mass effect due to risk of herniation; obtain imaging first

• Blood tests:
• Metabolic panel and renal function if considering loop diuretics
• Glucose and blood cultures if infection suspected

Diagnostic Criteria

• Ventriculomegaly on imaging: Ventricular dilation beyond age-adjusted norms
• Clinical symptoms attributable to raised ICP or mass effect: headaches, vomiting, cognitive decline, gait disturbance
• Elevated intracranial pressure (directly measured via ventricular catheter or inferred from imaging findings and clinical presentation)
• Evidence of CSF obstruction or impaired absorption: Imaging demonstrates obstruction site OR CSF flow studies abnormal
• Exclusion of other causes of ventriculomegaly (benign enlargement of subarachnoid spaces, cerebral atrophy, post-hemorrhagic enlargement without ongoing pressure elevation)

Differential Diagnosis Considerations

• Benign external hydrocephalus: Enlarged subarachnoid spaces with normal or mildly enlarged ventricles; typically self-limited in early childhood; normal development and head growth
• Benign familial macrocephaly: Normal-sized ventricles with proportional enlargement of head; normal development
• Cerebral atrophy: Ventricular enlargement with concurrent enlargement of cortical sulci and subarachnoid spaces

Medical Management (Temporary Measure or Adjunct)

• Loop diuretics: Furosemide (1 mg/kg/day IV or PO in divided doses)
• Reduces CSF production by decreasing choroid plexus secretion
• Mechanism: Inhibits Na-K-Cl cotransporter in choroid plexus epithelium
• Maximal effect requires concurrent potassium supplementation and monitoring of electrolytes
• Efficacy limited; typically ineffective as sole therapy for obstructive hydrocephalus
• Used primarily in post-hemorrhagic hydrocephalus in premature infants as temporizing measure while waiting for spontaneous resolution
• Complications: Hypokalemia, hypochloremic metabolic alkalosis, ototoxicity with chronic use

• Carbonic anhydrase inhibitors: Acetazolamide (10-30 mg/kg/day in divided doses)
• Reduces CSF production by 50% by inhibiting carbonic anhydrase in choroid plexus
• Often used as adjunctive therapy with furosemide
• Side effects: Paresthesias, metabolic acidosis, nephrolithiasis with chronic use
• Limited efficacy as monotherapy

• Osmotic therapy (acute management only):
• Mannitol (0.25-1 g/kg IV bolus) or hypertonic saline (3% NaCl 0.1-1 mL/kg/hour)
• Reduces brain water content and transiently lowers ICP
• Used for acute ICP crises while awaiting surgical intervention
• Does not address underlying pathology

Surgical Management (Definitive Treatment)

• Ventriculoperitoneal (VP) shunt: Most common definitive treatment
• Diverts CSF from lateral ventricle via catheter through subcutaneous tunnel to peritoneal cavity
• Indications: Obstructive hydrocephalus, communicating hydrocephalus with symptomatic ICP elevation, ventriculomegaly with developmental impact
• Mechanism: Unidirectional valve maintains pressure gradient (typically 1.0-2.0 mmHg at rest); newer programmable valves allow non-invasive pressure adjustment
• Complications (shunt-dependent morbidity):
• Shunt malfunction (occurs in 5-10% per year; accounts for 80% of shunt failures): Blockage, disconnection, migration; presents with headache, vomiting, lethargy, fontanelle bulging
• Shunt infection (ventriculitis; occurs in 5-15% of new shunts, highest in neonates): Fever, irritability, poor feeding, abdominal pain; requires antibiotics (intraventricular vancomycin + aminoglycoside) and shunt externalization/replacement
• Overdrainage: Subdural hematoma (especially in older children), slit ventricles with increased stiffness, intracranial hypotension
• Underdrainage: Persistent hydrocephalus symptoms despite shunt placement
• Long-term: Up to 50% of VP shunts require revision by adulthood due to complications or outgrowth

• Ventriculoatrial (VA) shunt: Diverts CSF to right atrium via catheter through internal jugular vein
• Reserved for: Abdominal pathology (peritoneal carcinomatosis, previous abdominal surgery, ascites), VP shunt failure
• Complications: Shunt nephritis (immune complex glomerulonephritis from chronic shunt infection/foreign body), cardiac dysrhythmias, septic thrombophlebitis

• Endoscopic third ventriculostomy (ETV): Creates communication between third ventricle and interpeduncular cistern
• Indications: Obstructive hydrocephalus from aqueductal stenosis, Chiari malformation, fourth ventricle obstruction (select cases)
• Mechanism: Bypasses obstruction by creating alternative CSF drainage pathway
• Success rate: 50-80% depending on patient age and etiology; higher success in older children
• Advantages: Avoids implanted foreign body, eliminates shunt dependence and infection risk
• Failure: Closure of ventriculostomy opening; may require ETV-choroid plexus cauterization combination
• Complications: Basilar artery injury, venous injury, meningitis, suboptimal opening, subdural hematoma

• Choroid plexus cauterization: Reduces CSF production by destroying choroid plexus epithelium
• Indications: Choroid plexus papilloma, rarely used as standalone therapy
• Effectiveness: 20-50% reduction in CSF production
• Combined with ETV in select cases for improved success

• Posterior fossa decompression: Addresses Chiari malformation and associated hydrocephalus
• Indications: Symptomatic Chiari I/II with hydrocephalus
• Technique: Suboccipital craniectomy,

Complications of untreated/decompensated hydrocephalus

• Herniation syndromes (emergency): transtentorial or tonsillar herniation as ventricular pressure exceeds compensatory reserve; heralded by the Cushing triad (hypertension, bradycardia, irregular respirations), anisocoria, decerebrate posturing, or abrupt apnea. Immediate neurosurgical CSF diversion (external ventricular drain or shunt tap) is the definitive maneuver; osmotherapy and head-of-bed elevation only buy time.
• Optic atrophy and permanent visual loss: chronic papilledema causes axonal ischemia at the disc; signaled by progressive visual field constriction or falling acuity. Remember papilledema may be absent in infants with open sutures, so its absence never excludes raised ICP.
• Neurocognitive and motor sequelae: periventricular white matter stretch injures the corticospinal fibers subserving the legs, producing spastic diplegia; language may be preserved out of proportion to reasoning (the "cocktail party" speech pattern). AAP developmental surveillance and formal neurodevelopmental follow-up are indicated in all shunted children.
• Endocrinopathy: hypothalamic–pituitary stalk distortion from third-ventricular dilation causes central precocious puberty or growth hormone deficiency.
• Chiari II brainstem decompensation in myelomeningocele infants (emergency): inspiratory stridor from vocal cord palsy, apnea, dysphagia, or opisthotonos — first assume shunt failure until proven otherwise.

Complications of treatment

• Shunt obstruction (emergency): proximal catheter occlusion by choroid plexus/debris or valve failure; recurrence of the child's prior symptom pattern (headache, vomiting, lethargy, bulging fontanelle) is the signal. Evaluate with a shunt series plus low-dose CT or rapid-sequence MRI (consistent with ACR Appropriateness Criteria/Image Gently radiation-sparing preference).
• Shunt infection/ventriculitis (emergency): coagulase-negative staphylococci and S. aureus predominate, usually within months of surgery; fever, irritability, and shunt-tract erythema. Per the 2017 IDSA healthcare-associated ventriculitis guideline, management is hardware removal with external drainage plus IV antibiotics; vancomycin is dosed to a 24-hour AUC/MIC of 400–600 (2020 IDSA/ASHP consensus), not to a trough goal.
• Overdrainage: siphoning produces subdural hygroma/hematoma and slit ventricle syndrome with intermittent postural headaches; programmable valves or antisiphon devices are the remedy.
• Distal complications: abdominal CSF pseudocyst (distension, tenderness), viscus perforation, catheter migration with somatic growth; VA shunts add shunt nephritis and thromboembolism.
• Late ETV failure: stoma closure can cause sudden, rapidly fatal decompensation — these children are not "shunt-free and safe."

• Sunset sign = tectal plate compression: forced downgaze with visible sclera above the iris localizes pressure to the dorsal midbrain (Parinaud territory). Paired with a bulging fontanelle and crossing head-circumference percentiles, it is the classic infant vignette.
• Aqueductal stenosis is the prototypic obstructive lesion: dilated lateral and third ventricles with a normal-sized fourth ventricle on imaging. If the stem adds adducted ("cortical") thumbs in a boy, think X-linked hydrocephalus from an L1CAM mutation.
• Best next step when a shunted child vomits and is sleepy: assume shunt failure — obtain a shunt series plus rapid-sequence MRI or low-dose CT and call neurosurgery. Per ACR/Image Gently principles, rapid MRI is preferred over repeated CT in these frequently imaged children. Do not wait for fever, and do not perform an LP.
• Lumbar puncture is contraindicated in obstructive hydrocephalus: removing lumbar CSF across a blocked ventricular outlet creates a craniospinal pressure gradient and precipitates tonsillar herniation. Image first — the single most common test-day trap.
• The association examiners love: myelomeningocele → Chiari II → hydrocephalus, with the majority requiring diversion. In such an infant, new stridor, apnea, or dysphagia means shunt malfunction/brainstem compression until disproven.
• Premature infant with grade III–IV intraventricular hemorrhage is the leading acquired cause; blood products scar arachnoid granulations, producing communicating hydrocephalus weeks after the bleed.
• Distractor to avoid — benign enlargement of the subarachnoid spaces: a thriving infant with familial macrocephaly, prominent frontal extra-axial fluid, and normal or near-normal ventricles needs reassurance and growth-curve follow-up, not a shunt.
• Papilledema is unreliable in infants: open sutures decompress the vault, so a normal fundus never excludes raised ICP; head circumference plotted serially is the more sensitive vital sign.
• Prevention counseling: USPSTF and ACOG recommend periconceptional folic acid supplementation for all people capable of pregnancy to reduce neural tube defects — and thereby Chiari II–associated hydrocephalus.